141 related articles for article (PubMed ID: 17762146)
21. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
22. [Resistance reversal effect of a novel taxane compound NPB304 and its collaboration with verapamil].
Mei M; Zhang Y; Ren JH; Xie D; Jia YF; Hu JP; Li Y; Dai JG; Chen XG
Yao Xue Xue Bao; 2014 Sep; 49(9):1279-88. PubMed ID: 25518327
[TBL] [Abstract][Full Text] [Related]
23. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
24. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
Orlowski S; Mir LM; Belehradek J; Garrigos M
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
[TBL] [Abstract][Full Text] [Related]
25. By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
Tsubaki M; Komai M; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
Leuk Res; 2014 Jan; 38(1):121-30. PubMed ID: 24239173
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
Young TE; Lundquist LJ; Chesler E; Weir EK
Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
[TBL] [Abstract][Full Text] [Related]
27. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
Belhoussine R; Morjani H; Lahlil R; Manfait M
Int J Cancer; 1997 Nov; 73(4):600-6. PubMed ID: 9389578
[TBL] [Abstract][Full Text] [Related]
28. Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Trojnar MK; Trojnar MP; Kimber-Trojnar Z; Szostakiewicz B; Zadrozniak A; Borowicz KK; Czuczwar SJ
Can J Physiol Pharmacol; 2008 Mar; 86(3):113-21. PubMed ID: 18418438
[TBL] [Abstract][Full Text] [Related]
29. Verapamil competes with doxorubicin for binding to anionic phospholipids resulting in increased internal concentrations and rates of passive transport of doxorubicin.
Speelmans G; Staffhorst RW; De Wolf FA; De Kruijff B
Biochim Biophys Acta; 1995 Sep; 1238(2):137-46. PubMed ID: 7548128
[TBL] [Abstract][Full Text] [Related]
30. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
31. Membrane effects of the antitumor drugs doxorubicin and thaliblastine: comparison to multidrug resistance modulators verapamil and trans-flupentixol.
Pajeva I; Todorov DK; Seydel J
Eur J Pharm Sci; 2004 Feb; 21(2-3):243-50. PubMed ID: 14757496
[TBL] [Abstract][Full Text] [Related]
32. Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test.
Del Pozo E; Ruiz-García C; Baeyens JM
Gen Pharmacol; 1990; 21(5):681-5. PubMed ID: 2276585
[TBL] [Abstract][Full Text] [Related]
33. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
[TBL] [Abstract][Full Text] [Related]
34. Reversal of multidrug resistance by verapamil and modulation by alpha 1-acid glycoprotein in wild-type and multidrug-resistant Chinese hamster ovary cell lines.
Chatterjee M; Robson CN; Harris AL
Cancer Res; 1990 May; 50(9):2818-22. PubMed ID: 1970277
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
Bennis S; Ichas F; Robert J
Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
[TBL] [Abstract][Full Text] [Related]
36. Effect of the exposure to gentamicin and diltiazem on the permeability of model membranes.
Trombetta D; Arena S; Tomaino A; Tita B; Bisignano G; De Pasquale A; Saija A
Farmaco; 2001; 56(5-7):447-9. PubMed ID: 11482775
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y
Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258
[TBL] [Abstract][Full Text] [Related]
38. Facilely accessible multidrug resistance modulator derived from sucrose.
Murakami N; Tamura S; Iwata E; Aoki S; Akiyama S; Kobayashi M
Bioorg Med Chem Lett; 2002 Nov; 12(22):3267-70. PubMed ID: 12392729
[TBL] [Abstract][Full Text] [Related]
39. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
